Active drug-coated flow diverter in a preclinical model of intracranial stenting.
Robert M KingAhmet PekerMark EpshteinJennifer M ArendsAlice B BrochuChristopher M RaskettKimiko J SlazasAjit S PuriAdam S ArthurDavid J FiorellaMatthew J GounisVania AnagnostakouPublished in: Journal of neurointerventional surgery (2023)
Heparin-coated flow diverters significantly reduced the number of new MSAs after 1 week follow-up, showing the potential to reduce TEC.